MCK
Mckesson (MCK)
NYSE
$763.40+$18.55 (+2.49%)
Price as of Jun 23, 2026 1:30 PM EDT
  • $87.2B
    Market Cap
  • 3.61%
    1-Year Change
  • Medical Distribution
    Industry

Key Performance

More
  • Earnings Score: 56
  • Momentum Score: 78
  • True Yield: 41
  • Financial Health Score: 62
TradeSmith Loading

Latest Research & News

$663.3 Bn Revenue Cycle Management Market Trends and Global Forecasts Report 2026-2035

The global revenue cycle management (RCM) market is projected to grow at a CAGR of 11.51% from $200.1 billion in 2026 to $663.3 billion by 2035, driven by widespread EHR adoption, shift to value-based care models, and increasing use of AI and automation. North America holds the largest market share due to its complex healthcare system and advanced technology infrastructure. Key players include 3M, Change Healthcare, Optum, and McKesson, though high implementation costs and regulatory complexity present challenges.

05/21/2026, 4:57 AM • GlobeNewswire

Global Healthcare Analytics Market is Predicted to Cross the USD 380 Billion Mark by 2034 | DelveInsight

The global healthcare analytics market is projected to grow from USD 56 billion in 2025 to USD 390 billion by 2034, with a CAGR of ~24%. Growth is driven by widespread EHR adoption, rising chronic disease prevalence, shift toward value-based care, AI/ML integration, and government digital health initiatives. North America leads with 44.36% market share, while Asia-Pacific emerges as a major growth engine.

05/06/2026, 1:00 PM • GlobeNewswire

Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032

The global robotic pharmacy prescription market is experiencing significant growth, expanding from USD 214.16 million in 2025 to USD 237.65 million in 2026, with a projected CAGR of 9.18% through 2032, reaching USD 396.21 million. The market is driven by automation adoption for medication safety and efficiency, workforce transformation toward clinical roles, and bundled solution procurement strategies across hospitals, clinics, and long-term care facilities.

04/09/2026, 4:57 AM • GlobeNewswire

Biopharmaceutical Third Party Logistics (Distribution Management, Packaging & Labeling, Transportation, Warehousing) Market Research and Global Forecast Report 2026-2032

The biopharmaceutical third-party logistics market is expected to grow from $140.03 billion in 2025 to $384.23 billion by 2032, with a CAGR of 15.51%. Growth is driven by rising product complexity, regulatory scrutiny, cold chain integrity demands, and technological advancements in digital tracking and specialized handling for biologics and gene therapies.

04/09/2026, 4:49 AM • GlobeNewswire

Evolve Founder Shayla King Opens Enrollment for The Performance + Happiness Lab to Help Senior Leaders Pursue Pay and Promotion

Evolve Executive Life Coaching founder Shayla King announced enrollment for The Performance + Happiness Lab, a coaching program designed to help senior leaders advance their careers while maintaining work-life balance. The program addresses challenges faced by high-performing executives who achieve results but experience burnout, helping them strengthen positioning, build influence, and pursue sustainable career growth.

03/31/2026, 12:57 AM • GlobeNewswire

Cardiology EHR: The Digital Pulse Behind a USD 5.44 Billion Cardiac Care Evolution by 2035

The global cardiology EHR market is valued at USD 3.52 billion in 2026 and is expected to reach USD 5.44 billion by 2035, growing at a 4.95% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Web/cloud-based EHR systems dominate the product segment, with ambulatory surgery centers expected to grow fastest by end-use category.

02/20/2026, 9:00 AM • GlobeNewswire

Software's Freefall Continues, Bitcoin Dips To 16-Month Lows: What's Moving Markets Thursday?

Software stocks plunged for an eighth consecutive session on Thursday, marking their longest losing streak since May 2021, as investors worry AI could undermine SaaS demand. Bitcoin fell 9% to $66,000, hitting 16-month lows, while commodities suffered broad declines. Major indices traded modestly lower, with notable losers including Estée Lauder (down 23% on tariff concerns), Palantir (down 4.4%), and Qualcomm (down 7% on weak guidance). Winners included McKesson (up 15.8%), Regal Rexnord (up 13%), and Uber (up 3%).

02/05/2026, 1:15 PM • Benzinga

How the Largest IPO of 2025 Could Be Healthy for Your Portfolio

Medline Industries, the largest IPO of 2025, is positioned as an attractive investment opportunity. The Chicago-based medical supply company has demonstrated strong historical growth with 18% average annual sales growth since 1966 and 50 consecutive years of net sales growth. With a $375 billion total addressable market and solid free cash flow projections, analysts expect continued momentum, though the stock trades at a lofty P/E multiple of 28.

02/05/2026, 1:15 AM • The Motley Fool

AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies

AOP Health US announced expanded distribution of Rapiblykâ„¢ (landiolol), an FDA-approved ultra-short-acting beta-blocker for treating rapid heart rates in critical care settings. The drug is now available through four major pharmaceutical wholesalers: Cardinal, Cencora Specialty Distribution, McKesson Corporation, and Morris & Dickson, enhancing accessibility for hospitals and health systems nationwide.

01/12/2026, 9:00 AM • GlobeNewswire

Automated Pharmacy Compounding Systems Market Growing Toward USD 5.27 Billion in 2035

The global automated pharmacy compounding systems market is projected to grow from USD 2.95 billion in 2025 to USD 5.27 billion by 2035, driven by the need to reduce medication errors, demand for personalized medicine, and stringent regulatory standards.

12/05/2025, 10:00 AM • GlobeNewswire

Iterum Therapeutics Provides Business Update

Iterum Therapeutics reports expanding market access for ORLYNVAHâ„¢, securing nearly 25% insurance coverage in the U.S. and signing a Medicare Part D rebate agreement with a top Pharmacy Benefit Manager, with potential coverage starting in Q1 2026.

12/05/2025, 8:00 AM • GlobeNewswire

Healthcare Supply Chain Management Market Grows at 11.05% CAGR by 2034

The global healthcare supply chain management market is projected to grow from $3.60 billion in 2025 to $9.20 billion by 2034, with a CAGR of 11.05%. North America leads the market, driven by technological advancements, AI integration, and demand for efficient healthcare logistics.

10/14/2025, 11:00 AM • GlobeNewswire

Practice Management Systems Market is Projected to Reach US$36.33 billion at CAGR of 9.3% Amid Need for Operational Efficiency & Automation | The Insight Partners

The Practice Management Systems market is expected to grow to $36.33 billion by 2031, with a 9.3% CAGR, driven by digital healthcare solutions, operational efficiency needs, and increasing telemedicine adoption.

09/29/2025, 10:30 AM • Benzinga

AI in Medical Billing Market Size to Surpass USD 22.46 Billion by 2032, Owing to the Rising Demand for Automation, Accuracy, and Regulatory Compliance in Healthcare | Research by SNS Insider

The AI in Medical Billing Market is projected to grow from USD 3.69 billion in 2024 to USD 22.46 billion by 2032, driven by healthcare industry needs for automation, accuracy, and regulatory compliance.

08/21/2025, 2:57 AM • GlobeNewswire

Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability

Synergy CHC Corp reported its tenth consecutive quarter of profitability, with revenue of $8.1 million, a gross margin of 76.7%, and net income of $1.5 million. The company expanded its FOCUSfactor brand internationally and secured new North American retail distribution partnerships.

08/14/2025, 8:00 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$744.45
$757.18
$744.85
1-Year Range
$659.01
$995.69
$744.85
Latest Close$744.85
Change
-$5.78 (-0.78%)
Volume1,454,601
Market Cap$87.2B
Shares Outstanding117.1M
P/E (TTM)19.41
Diluted EPS (TTM)$38.37
Enterprise Value$89.8B

Information as of 06/22/2026

Company Profile

$87.2B
Market Cap
$4.8B
Net Income
Sector: Healthcare
Industry: Medical Distribution
6555 State Highway 161, Irving, TX, United States, 75039
972 446 4800

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Key Executives

  • Brian S. Tyler
  • Britt J. Vitalone
  • Kenny K. Cheung
  • Martin Koffel
  • Michele Lau

Current Ownership Distribution

  • Mutual Funds2.1B (50.15%)
  • Institutions2.1B (49.84%)
  • Insiders385,434 (0.009%)
  • Other0 (0.00%)